Colchicine repurposing for myh7-associated dilated cardiomyopathy treatment
A novel approach to treat MYH7-associated dilated cardiomyopathy by restoring the MEF2C-desmin signaling axis or using colchicine to improve cardiomyocyte contractility. This utilizes an FDA-approved drug, offering a rap...